Exploring the Therapeutic Benefits of Pranayama (Yogic Breathing): A Systematic Review.

Pranayama therapeutic benefit yogic breathing

Journal

International journal of yoga
ISSN: 0973-6131
Titre abrégé: Int J Yoga
Pays: India
ID NLM: 101313247

Informations de publication

Date de publication:
Historique:
received: 26 04 2019
revised: 14 05 2019
accepted: 31 08 2019
entrez: 17 7 2020
pubmed: 17 7 2020
medline: 17 7 2020
Statut: ppublish

Résumé

Pranayama (yogic breathing) has demonstrated numerous beneficial health effects. At present, there are no systematic reviews evaluating the beneficial health effects of pranayama alone as a practice. The aim of this study is to perform a systematic review about the beneficial health effects of pranayama. Data were obtained using a stepwise search process by searching the online PubMed, Web of Science, and SciVerse Scopus databases using keywords. Controlled clinical trials in humans, using "Pranayama" as an intervention with an appropriate control group and evaluating health-related outcomes were selected for inclusion. Initial database searching indicated 669 potentially eligible articles, of which 18 studies satisfying the inclusion/exclusion criteria were selected. All were controlled trials, of which 13 were randomized and 1 was a crossover study. Number of participants ranged from 16 to 160, and the duration of pranayama practice varied from 4 days to 6 months. Studies demonstrated a significant effect on cardiorespiratory functions, in patients with bronchial asthma, with the improvement of pulse rate, systolic blood pressure, and respiratory function measurements. Furthermore, reduction in the frequency of attacks, severity, and medication requirement was also observed, with improved quality of life (QOL). In patients with chronic obstructive pulmonary disease, symptom, activity, and impact scores were improved. QOL improvement was also noted in cancer patients. Available evidence on pranayama indicates physiological and psychological benefits. Beneficial effects were mostly observed in patients with respiratory diseases such as bronchial asthma. It also helped those with cancer and cardiovascular disease. However, further high-quality randomized trials are required to provide definitive evidence.

Sections du résumé

BACKGROUND BACKGROUND
Pranayama (yogic breathing) has demonstrated numerous beneficial health effects. At present, there are no systematic reviews evaluating the beneficial health effects of pranayama alone as a practice.
AIM OBJECTIVE
The aim of this study is to perform a systematic review about the beneficial health effects of pranayama.
METHODS METHODS
Data were obtained using a stepwise search process by searching the online PubMed, Web of Science, and SciVerse Scopus databases using keywords. Controlled clinical trials in humans, using "Pranayama" as an intervention with an appropriate control group and evaluating health-related outcomes were selected for inclusion.
RESULTS RESULTS
Initial database searching indicated 669 potentially eligible articles, of which 18 studies satisfying the inclusion/exclusion criteria were selected. All were controlled trials, of which 13 were randomized and 1 was a crossover study. Number of participants ranged from 16 to 160, and the duration of pranayama practice varied from 4 days to 6 months. Studies demonstrated a significant effect on cardiorespiratory functions, in patients with bronchial asthma, with the improvement of pulse rate, systolic blood pressure, and respiratory function measurements. Furthermore, reduction in the frequency of attacks, severity, and medication requirement was also observed, with improved quality of life (QOL). In patients with chronic obstructive pulmonary disease, symptom, activity, and impact scores were improved. QOL improvement was also noted in cancer patients.
CONCLUSIONS CONCLUSIONS
Available evidence on pranayama indicates physiological and psychological benefits. Beneficial effects were mostly observed in patients with respiratory diseases such as bronchial asthma. It also helped those with cancer and cardiovascular disease. However, further high-quality randomized trials are required to provide definitive evidence.

Identifiants

pubmed: 32669763
doi: 10.4103/ijoy.IJOY_37_19
pii: IJY-13-99
pmc: PMC7336946
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

99-110

Informations de copyright

Copyright: © 2020 International Journal of Yoga.

Déclaration de conflit d'intérêts

There are no conflicts of interest.

Références

J Diabetes Res. 2016;2016:6979370
pubmed: 26788520
Asia Pac J Oncol Nurs. 2016 Apr-Jun;3(2):199-204
pubmed: 27981159
BMC Complement Altern Med. 2014 Sep 02;14:328
pubmed: 25183419
Chest. 2004 May;125(5):1951-2
pubmed: 15136413
Int J Yoga. 2015 Jan;8(1):47-53
pubmed: 25558133
Indian J Physiol Pharmacol. 1992 Apr;36(2):105-8
pubmed: 1506070
J Adv Nurs. 1984 Mar;9(2):127-33
pubmed: 6562134
Clin Rehabil. 2013 Feb;27(2):133-41
pubmed: 22837543
Aust J Physiother. 2009;55(2):129-33
pubmed: 19463084
J Clin Diagn Res. 2014 Dec;8(12):BC04-6
pubmed: 25653936
Evid Based Complement Alternat Med. 2007 Dec;4(4):487-91
pubmed: 18227916
J Assoc Physicians India. 2004 Mar;52:203-6
pubmed: 15636309
Lancet. 1990 Jun 9;335(8702):1381-3
pubmed: 1971670
J Altern Complement Med. 2012 May;18(5):473-9
pubmed: 22525009
Indian J Physiol Pharmacol. 2004 Jul;48(3):269-85
pubmed: 15648399
Anc Sci Life. 2016 Oct-Dec;36(2):72-77
pubmed: 28446827
J Cardiovasc Thorac Res. 2016;8(4):170-175
pubmed: 28210473
Indian J Physiol Pharmacol. 2005 Oct-Dec;49(4):469-74
pubmed: 16579402
Ann N Y Acad Sci. 2005 Nov;1056:242-52
pubmed: 16387692
Evid Based Complement Alternat Med. 2012;2012:165410
pubmed: 23008738
Indian J Physiol Pharmacol. 2009 Apr-Jun;53(2):169-74
pubmed: 20112821
Int J Appl Basic Med Res. 2014 Jul;4(2):67-71
pubmed: 25143878
J Altern Complement Med. 2004 Apr;10(2):261-8
pubmed: 15165407
J Altern Complement Med. 2009 Jul;15(7):711-7
pubmed: 19534616
J Altern Complement Med. 2015 Oct;21(10):586-92
pubmed: 26196166
Iran J Allergy Asthma Immunol. 2014 Feb;13(1):55-60
pubmed: 24338229
J Clin Diagn Res. 2014 Jan;8(1):10-3
pubmed: 24596711
Indian J Physiol Pharmacol. 1992 Oct;36(4):229-33
pubmed: 1291472
Int J Yoga. 2013 Jul;6(2):104-10
pubmed: 23930028
Med Hypotheses. 2006;67(3):566-71
pubmed: 16624497
Int J Yoga. 2009 Jan;2(1):22-5
pubmed: 21234211
Int J Yoga. 2011 Jul;4(2):49-54
pubmed: 22022122
J Interpers Violence. 2008 Dec;23(12):1800-8
pubmed: 18319369

Auteurs

Ranil Jayawardena (R)

Department of Physiology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia.

Priyanga Ranasinghe (P)

Department of Pharmacology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.

Himansa Ranawaka (H)

Department of Physiology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.

Nishadi Gamage (N)

Department of Pharmacology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.

Dilshani Dissanayake (D)

Department of Physiology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.

Anoop Misra (A)

Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, Diabetes Foundation and National Diabetes Obesity and Cholesterol Foundation, New Delhi, India.

Classifications MeSH